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Background: Remote ischemic preconditioning (RIPC) and postconditioning (RpostC) have protective effects on
ischemia and reperfusion injury. The effects have been reported to activate heme oxygenase-1 (HO-1) and attenuate
nuclear factor kappa B (NF-κB) and subsequently reduce systemic inflammation. Ischemic preconditioning prevented
inflammatory responses by modulating HO-1 expression in endotoxic shock model. Therefore, we investigated whether
RpostC could have protective effects on lipopolysaccharide (LPS)-induced systemic inflammation.
Methods: The LPS-induced sepsis mice received LPS (20 mg/kg) intraperitoneally. Remote ischemic conditioning was
induced with three 10-min ischemia/10-min reperfusion cycles of the right hind limbs using tourniquet before LPS
injection (RIPC) or after LPS injection (RpostC). The effects of RIPC and RpostC were examined for the survival rate,
serum cytokines, NF-κB, HO-1 and liver pathology in the LPS injected mice.
Results: Survival rate within 120 hours significantly increased in the LPS injected and remote ischemic conditioned
mice than in LPS only injected mice (60-65% vs 5%, respectively, p < 0.01). Tumor necrosis factor-alpha (TNF-α),
interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) increased markedly in the LPS only injected mice, however, remote
ischemic conditioning suppressed the changes (p < 0.05). Interleukin-10 (IL-10) level was significantly higher in the LPS
injected and RpostC treated mice than in the LPS only injected mice (p = 0.014). NF-κB activation was significantly
attenuated (p < 0.05) and HO-1 levels were substantially higher in the LPS injected and remote ischemic conditioned
mice than in the LPS only injected mice. Neutrophil infiltration was significantly attenuated in the LPS injected and
remote ischemic conditioned mice than in the only LPS injected mice (p < 0.05).
Conclusions: RpostC attenuated inflammatory responses and improved survival outcomes of mice with LPS-induced
systemic inflammation. The mechanism may be caused by modifying NF-κB mediated expression of cytokines.
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Severe sepsis is a life-threatening clinical disease induced
by infection or other various causes and is characterized
by systemic inflammation and multiple organ injury. In
spite of development of new therapies for sepsis, mortal-
ity rate is approximately 30% in people with severe sep-
sis and up to 45% of those in septic shock [1]. Therefore,* Correspondence: yourejoice@korea.ac.kr
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and developed.
The liver plays an active role in the inflammatory re-
sponse to endotoxemia and sepsis by producing acute
phase proteins and proinflammatory cytokines [2,3]. Nu-
clear factor kappa B (NF-κB) is activated in an early step
of pathogenesis of organ injury in sepsis [4,5]. However,
NF-κB activation is known to be inhibited by heme
oxygenase-1 (HO-1) activation [6,7]. The expression of
HO-1 can be induced by ischemic preconditioning [8,9],
ischemic postconditioning [10,11] or remote ischemic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ditioning (RIPC) or postconditioning (RpostC), achieved
with repeated brief periods of ischemia and reperfusion
(I/R) of one organ before or after prolonged ischemic
period has been reported to protect distant organs against
ischemic injury [15]. The effects are associated with down-
regulation of key steps leading to cell death and systemic
inflammatory responses [10,15-17]. Indeed, intestinal ische-
mic preconditioning prevented inflammatory responses by
modulating intestinal HO-1 expression in endotoxic shock
model [18]. Furthermore, Wen et al. [19] reported upregu-
lation of HO-1 by chemical inducers prevented lipopolysac-
charide (LPS)-induced acute hepatic injury.
Therefore, we hypothesized that RpostC may attenuate
LPS-induced systemic inflammatory responses by inducing
HO-1 expression and attenuating NF-κB activation. There
has been little work, however, examining the effects of
RpostC in the setting of LPS-induced sepsis model. We in-
vestigated whether RpostC could improve survival rate and
suppress LPS-induced pro-inflammatory cytokines, NF-κB
activation, and hepatic inflammation. Also, we assessed if
RpostC might upregulate HO-1, leading to the attenuation
of LPS-induced systemic inflammation.Methods
Animals
Six-week-old male BALB/c mice (Hanlim Co. Ltd.,
Hwasung, South Korea) were used in this study. All
animals were maintained in a constant-temperature (24 ±
2°C) room with 12-hour cycles of light and dark. The mice
had ad libitum access to food and water.
The LPS-induced sepsis model was made by injecting
20 mg/kg of LPS (E, Coli O127: B8; Sigma, St. Louis,
MO, USA) in 0.4 ml physiologic saline intraperitoneally
(i.p.). Remote conditioning was induced with three 10-min
ischemia/10-min reperfusion cycles of the right hind limbs
using tourniquet.
All experimental procedures involving animals were car-
ried out in accordance with the NIH guide for the Care and
Use of Laboratory Animals issued by the Korea University
School of Medicine. The study was approved by the Ethical
Committee on Animal Research of the Korea University
College of Medicine.
Mice were randomly divided into six experimental
groups: (1) Saline group, received an injection of saline
i.p.; (2) LPS group, received an injection of LPS (20 mg/kg,
i.p.); (3) RIPC/Saline group, subjected to remote condi-
tioning, followed immediately by an i.p. injections of
saline; (4) Saline/RpostC group, received an injection of
saline i.p., followed immediately by remote conditioning;
(5) RIPC/LPS group, subjected to remote conditioning,
followed immediately by an injection of LPS (20 mg/kg,
i.p.); (6) LPS/RpostC group, received an injection of LPS(20 mg/kg, i.p.), followed immediately by remote condi-
tioning (Figure 1).
Protocol 1: Survival rate
Survival rate was measured in the LPS group (n = 40),
RIPC/LPS group (n = 20), and LPS/RpostC (n = 20) groups,
every 8 hours for 120 hours. After 5 days, all living mice
were euthanatized with intraperitoneal injection of thio-
pental sodium (50 mg/kg).
Protocol 2: cytokines, NF-κB, HO-1 and liver pathology
Mice were randomly divided into six experimental groups
(n = 6, each group) according to each target measurements.
Serum pro-inflammatory cytokines (TNF-α, IL-6) levels
were measured at 1 hour and 4 hours after LPS (or saline)
injection and another pro-inflammatory cytokine (IL-1β)
and anti-inflammatory cytokine (IL-10) levels were at
1 hour after LPS injection (or saline) in each group. Blood
was obtained directly from the heart. Cytokines were de-
termined in the serum using commercial enzyme linked
immunosorbent assay (ELISA) assay kits (R&D Systems,
Minneapolis, USA). After sampling via cardiac puncture,
serum was collected by centrifuging the clotted blood at
4,000 × g, 4°C, 10 min. Detection ranges of TNF-α, IL-1β,
and IL-6 are 0.36-7.21, 0.46-4.80, and 1.3-1.8 pg/ml, re-
spectively. The minimal detectable doses of TNF-α, IL-1β,
IL-6, and IL-10 are less than 1.88, 2.31, 1.6, and 4.0 pg/ml,
respectively.
The NF-κB activity was measured at 1 hour after LPS
(or saline) injection in liver tissue homogenate. Nuclear
protein was extracted in the liver tissue using a commer-
cial kit according to the instruction manual (Nuclear
Extract Kit, Active Motif, California, USA). Nuclear pro-
tein concentration was determined using BCA protein
assay kit (Pierce, Rockford, IL, USA). Five μg of nuclear
protein from liver tissues was used to assess NF-kB activa-
tion using the NF-κB p65 assay kit (TransAM p65, Active
Motif, USA) according to the manufacturer’s instruction.
HO-1 was measured in the supernatant of homoge-
nized liver extracts at 1 hour and 12 hours after LPS (or
saline) injection using the mouse HO-1 ELISA kit ac-
cording to the manufacturer’s instruction (Cusabio Bio-
Tech, Wuhan, China). One hundred mg of liver tissue
was rinsed with phosphate buffered saline (PBS) and ho-
mogenized in 1 ml of PBS. The homogenate was stored
overnight at −20°C. After two freeze-thaw cycles were per-
formed to break the cell membranes, the homogenates
were centrifuged for 5 min at 5000 × g, 4°C. The super-
natant was used for HO-1 assay with 1,500-fold dilution
with sample diluents. Detection range of the assay is
31.25 ng/ml - 2000 ng/ml, and the minimal detectable
dose of HO-1 is less than 7.8 pg/ml.
Liver tissues were collected at 12 hours after LPS in-
jection. The right lobes of the liver were fixed with 10%
Figure 1 Experimental protocol. Mice were randomly divided into six experimental groups (n = 6, each group) according to each target
measurements: (1) Saline group, received an injection of saline (intraperitoneally: i.p.); (2) LPS group, received an injection of LPS (20 mg/kg, i.p.);
(3) RIPC/Saline group, subjected to remote conditioning, followed immediately by an i.p. injections of saline; (4) Saline/RpostC group, received an
injection of saline i.p., followed immediately by remote conditioning; (5) RIPC/LPS group, was subjected to remote conditioning, followed immediately
by an injection of LPS (20 mg/kg, i.p.); (6) LPS/RpostC group, received an injection of LPS (20 mg/kg, i.p.), followed immediately by remote conditioning.
Remote conditioning was induced with three 10-min ischemia/10-min reperfusion cycles of the right hind limbs using tourniquet.
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embedded in paraffin, and cut into 4 μm sections. Tissue
sections were then stained with anti-Ly-6G stain for neu-
trophil count. Neutrophil accumulation was quantified by
a researcher who was blinded towards experiment proto-
col. Brown color-stained PMNs (polymorphonuclear neu-
trophils) were counted in 16 random high-power fields
(400x), and the averaged values were reported.Statistical analysis
All data were expressed as the mean ± standard error of the
mean (SEM). Survival data were analyzed using Kaplan-
Meier log-rank test. For detection of significant differences
between groups a Kruskal-Wallis test was used. A post hoc
analysis was then performed with pairwise Mann–Whitney
U tests. For all tests, a p-value less than 0.05 was con-
sidered statistically significant. All statistical analyses
were performed using SPSS, version 12.0 (SPSS®, Chicago,
Illinois, USA).Results
Survival rate
The number of survivors was 2/40, 13/20, and 12/20 in
the LPS, RIPC/LPS, and LPS/RpostC groups, respectively.The survival rate of RIPC/LPS and LPS/RpostC groups
were significantly greater than that of LPS group (p < 0.001,
p < 0.01, respectively) (Figure 2). There was no significant
difference between the RIPC/LPS and LPS/RpostC groups.
Cytokines
The TNF-α level was significantly lower in the RIPC/
LPS group than in the LPS group at 1 hour after LPS ad-
ministration (p = 0.009) and was significantly lower in the
RIPC/LPS and LPS/RpostC group than in the LPS group
at 4 hours after LPS administration (p = 0.006 and p =
0.006, respectively) (Figure 3A).
IL-6 levels in the RIPC/LPS and LPS/RpostC group
revealed a significant decrease compared with those in
LPS group at 4 hours (p = 0.019, p = 0.03, respectively)
(Figure 3B).
The IL-1β level was significantly lower in the LPS/RpostC
group than in the LPS group (p = 0.013) (Figure 3C).
Serum IL-10 level was significantly higher in the
RpostC/LPS group compared with LPS group (p = 0.014)
(Figure 3D).
NF-κB DNA binding activity
NF-κB DNA binding activity in the RIPC/LPS and
LPS/RpostC group revealed a significant decrease when
Figure 2 Survival rate. The survival rate of RIPC/LPS (n = 20) and LPS/RpostC (n = 20) groups were significantly greater than that of LPS group
(n = 40) (p < 0.001, p < 0.01, respectively). There was no significant difference between the RIPC/LPS and LPS/RpostC groups. LPS group, received
an injection of LPS (20 mg/kg, i.p.); RIPC/LPS group, was subjected to remote conditioning, followed immediately by an injection of LPS (20 mg/
kg, i.p.); LPS/RpostC group, received an injection of LPS (20 mg/kg, i.p.), followed immediately by remote conditioning. RIPC: remote ischemic
preconditioning, RpostC: remote ischemic postconditioning.
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p = 0.006, respectively) (Figure 4).
HO-1 activity
Quantification of the HO-1 levels was substantially higher
in the RIPC/LPS and LPS/RpostC groups compared with
the LPS group at 1 hour (Figure 5) but significant differ-
ence were not found. There were no significant differences
across all groups at 12 hours.
Liver histopathological changes
No significant histologic alterations in the liver specimens
were observed in Saline group (Figure 6A), RIPC/Saline
(Figure 6B) and Saline/RpostC (Figure 6C). Severe patho-
logic abnormalities including infiltrating neutrophil cells
were seen in the LPS group (Figure 6D). Neutrophil accu-
mulation within the sinusoid of the liver was substantially
reduced in the RIPC/LPS (Figure 6E) and LPS/RpostC
group (Figure 6F) when compared with that in the LPS
group. Quantification of intrahepatic sinusoidal neutro-
phils by counting the brown color stained PMNs in 16
random high power fields (400×) in the RIPC and RpostC
groups revealed a significant neutrophil count decrease
compared with that of the LPS group (p < 0.001).
Discussion
RIPC and RpostC improved survival and suppressed pro-
inflammatory cytokines, NF-κB activation, and hepatic in-
flammation in the LPS-induced sepsis mice model. The
present study has shown that RpostC has also protective
effects on LPS-induced endotoxemia as RIPC.The survival rate of remote ischemic conditioned mice in
the LPS-induced systemic inflammation model amounted
to 60-65%, while the survival rate of unconditioned LPS
injected mice was 5% in this study. The pharmacologic
studies with cerivastatin or imipramine in LPS (15 –
20 mg/kg, i.p.) induced sepsis mice model showed that the
survival rate of those treatment groups were 60 – 70% and
that survival rate of non-treatment group were 10 – 20%
[20,21]. This result suggests that RIPC and RpostC im-
proved survival rates to an extent comparative to some
pharmacologic therapies.
Clinical and experimental studies have shown that LPS-
induced sepsis can lead to a rapid simultaneous secretion
of two functionally heterogeneous groups of cytokines:
pro-inflammatory cytokines (e.g., TNF-α, IL-1β and IL-6)
and anti-inflammatory (e.g., IL-10) [22]. The correlation
between TNF-α or IL-6 level and severity of disease ex-
hibit the importance of these cytokines in septic shock
[23-25]. Cytokine levels increased in a dose dependent
manner. The dosage of LPS, 20 mg/kg used in this study
was chosen as indicated by our preliminary experiment
and other studies [26]. A single injection of high-dose LPS
induces a very rapid, but transient, systemic cytokines with
peak levels between 1.5 and 4 hours that began to decline
at 8 hours [27]. Our preliminary study showed that TNF-
α peaked at 1 hour after LPS injection, while IL-6 peaked
at 4 hours after LPS injection. Therefore, we measured
TNF-α, IL-1β, IL-6, and IL-10 plasma at 1 and/or 4 hours
after LPS or saline administration.
RIPC significantly suppressed the release of TNF-α and
IL-6 and RpostC also significantly suppressed the release
Figure 3 Effects of RIPC and RpostC on levels of TNF-α, IL-6, IL-1β and IL-10. The concentration of TNF-α (A) and IL-6 (B) levels were
measured at 1 hour and 4 hours after LPS (or saline) injection. IL-1β (C) and IL-10 (D) levels were at 1 hour after LPS injection (or saline) in each
group. Mice were treated with saline (Saline group), RIPC plus saline (RIPC/Saline group), saline plus RpostC (Saline/RpostC group), LPS (20 mg/kg,
i.p.; LPS group), RIPC plus LPS (RIPC/LPS group), and LPS plus RpostC (LPS/RpostC group). i.p.: intraperitoneal. RIPC: remote ischemic preconditioning,
RpostC: remote ischemic postconditioning. Data are expressed as mean ± SEM (n = 6 in each group). † P < 0.05 versus Saline, RIPC/Saline, Saline/
RpostC at 1 h after LPS injection or saline injection. *P < 0.05 versus LPS group at 1 h after LPS injection or saline injection. ‡ P < 0.05 versus Saline,
RIPC/Saline, Saline/ RpostC at 4 h after LPS injection or saline injection. # P < 0.05 versus LPS group at 4 h after LPS injection or saline injection. ND,
not detectable.
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inflammatory cytokine IL-10. This was a finding similar to
a previous study in which ischemic post-conditioning had
caused a significant reduction in systemic inflammatory
response [10].
In immune and inflammatory responses, NF-κB is a
critical transcription factor and plays a crucial role through
the regulation of genes encoding pro-inflammatory cyto-
kines (e.g., TNF-α, IL-1β, IL-6), adhesion molecules, che-
mokines (e.g., interleukin-8), and monocyte chemotactic
protein-1 (MCP-1) [28]. Therefore, NF-κB is activated early
in the pathogenesis of organ injury in sepsis [4,5]. In
models of sepsis, greater levels of nuclear accumulation of
NF-κB are associated with higher rates of mortality and
worse clinical outcomes [29]. Contrariwise, suppression of
NF-κB activation decreases acute inflammatory responsesand organ dysfunction outcome [29] and down-regulation
of NF-κB activation could be a suitable therapeutic target
in sepsis. This present study provides evidence that RIPC
and RpostC decreases NF-κB DNA binding activity in the
liver during endotoxemia. Also, this result may be related
to in less death in RIPC and RpostC treated groups.
Some studies have reported that NF-κB activation and
nuclear translocation are inhibited by HO-1 [6,7]. HO-1
is an enzyme catalyzing the degradation of heme into
carbon monoxide, biliverdin, and free iron [11]. HO-1
and its by-products have been shown to promote cyto-
protection from oxidative stress, apoptotic cell death, and
cell injury during ischemia/reperfusion [30,31]. Ischemic
pre-conditioning and post-conditioning protect against
I/R injury and reduce systemic pro-inflammatory cytokine
release by induction of HO-1 [9-11,30]. More importantly,
Figure 4 NF-κB DNA binding activity. The NF-κB activity was measured at 1 hour after LPS (or saline) injection in liver tissue homogenate. Mice
were treated with saline (Saline group), RIPC plus saline (RIPC/Saline group), saline plus RpostC (Saline/RpostC group), LPS (20 mg/kg, i.p.; LPS
group), RIPC plus LPS (RIPC/LPS group), and LPS plus RpostC (LPS/RpostC group). i.p.: intraperitoneal. RIPC: remote ischemic preconditioning,
RpostC: remote ischemic postconditioning. Data are expressed as mean ± SEM (n = 6 in each group). *P < 0.05 versus LPS group. † P < 0.05 versus
Saline, RIPC/Saline, Saline/RpostC.
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tection against LPS-induced liver injury in rats [19]. HO-1
may diminish extravascular edema formation and endo-
thelial cell swelling by virtue of its anti-inflammatory,
anti-apoptotic and anti-proliferative actions, resulting in
reduced microvascular compression and improved organFigure 5 HO-1 activity. Quantification of the HO-1 levels was higher in th
LPS or saline injection (p < 0.05). Mice were treated with saline (Saline grou
RpostC group), LPS (20 mg/kg, i.p.; LPS group), RIPC plus LPS (RIPC/LPS gro
remote ischemic preconditioning, RpostC: remote ischemic postconditionin
versus LPS group. † P < 0.05 versus Saline.perfusion [32,33]. Another aim of this study was to deter-
mine if RpostC are associated with the activation of HO-1
as the protective mechanism for LPS induced hepatic
damage. HO-1 activation was substantially increased in
the RIPC/LPS and LPS/RpostC groups when compared
with that in the LPS group. However, this study did note RIPC/LPS and LPS/RpostC compared with Saline group at 1 h after
p), RIPC plus saline (RIPC/Saline group), saline plus RpostC (Saline/
up), and LPS plus RpostC (LPS/RpostC group). i.p.: intraperitoneal. RIPC:
g. Data are expressed as mean ± SEM (n = 6 in each group). *P < 0.05
Figure 6 (See legend on next page.)
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Figure 6 Liver histopathological changes. (A) Saline group (B) RIPC/Saline (C) Saline/RpostC group (D) LPS group (E) RIPC/LPS group (F) LPS/
RpostC group. Neutrophil accumulation within liver sinusoid substantially reduced in the RIPC/LPS group (E) and LPS/RpostC group (F) compared
with that in the LPS group (D) at 12 h after LPS injection. The brown colored neutrophils are stained with anti-mouse Ly-6G (black arrows).
Magnification × 400. (G) Quantification of intrahepatic sinusoidal neutrophils by counting PMNs in 16 random high-power fields. Magnification × 400.
Mice were treated with saline (Saline group), RIPC plus saline (RIPC/Saline group), saline plus RpostC (Saline/RpostC group), LPS (20 mg/kg, i.p.;
LPS group), RIPC plus LPS (RIPC/LPS group), and LPS plus RpostC (LPS/RpostC group). i.p.: intraperitoneal. RIPC: remote ischemic preconditioning,
RpostC: remote ischemic postconditioning. Data are expressed as mean ± SEM (n = 6 in each group). *P < 0.05 versus LPS group. Data are † P < 0.05
versus Saline, RIPC/Saline, Saline/RpostC.
Kim et al. Journal of Inflammation 2014, 11:16 Page 8 of 9
http://www.journal-inflammation.com/content/11/1/16show significant differences. A previous study showed that
intestinal ischemic preconditioning significantly reduced
the LPS-induced expression of inflammatory cytokine in
intestine and lung, while ischemic preconditioning select-
ively increased HO-1 mRNA expression in only intestine
and there was no expression in lungs (18). Therefore, it is
possible that HO-1 activation may not be shown in liver.
Further study is need for this HO-1 activation.
Hepatocyte vacuolation and nodular necrosis were ob-
servable at 12 hours post-LPS-injection (20 mg/kg, i.p.)
and mice began to die within 16 hours of LPS injection
in our study [34]. Therefore, liver tissues were collected at
12 hours after LPS injection. Histological examinations of
liver sections from LPS-treated mice revealed infiltrated
neutrophil and necrotic hepatocytes. However, RIPC and
RpostC suppressed significantly LPS-induced intrahepatic
sinusoidal neutrophils infiltration. These results seem to
be correlated to survival rate.
The anti-inflammatory effects of remote ischemic con-
ditioning were observed in mice, which will most likely
yield different results in humans [35] and the effects of
RIPC or RpostC could be questionable in septic patients.
Nevertheless, intermittent pneumatic compression is rou-
tinely applied to ICU patients and it might be used as an
alternative method of IPC. Therefore, clinical trials would
be needed to establish its potential role for treatment of
sepsis in humans.
Severe sepsis and septic shock have been responsible
for the high morbidity and mortality among intensive
care unit (ICU) patients. Mortality rates have decreased
considerably with the discovery of antimicrobial agents.
However, morbidity and mortality of sepsis have steadily
increased due to the emergence of antimicrobial-resistant
microorganisms [36]. Also, antimicrobial agents them-
selves often result in irreversible organ failure [37]. There-
fore, this study attempts to understand innate protective
mechanisms and develop new therapies against sepsis.
In summary, both RIPC and RpostC attenuated NF-κB
activation and reduced production of pro-inflammatory
cytokines and increased anti-inflammatory cytokines
release and attenuated hepatic injury and improved sur-
vival rate in LPS-induced systemic inflammation model.
These results suggest that RIPC and RpostC may be a
useful therapeutic approach in the treatment of sepsis.Conclusions
The present study demonstrated that not only RIPC but
RpostC attenuated inflammatory responses and im-
proved survival of mice with LPS-induced systemic in-
flammation by modifying NF-κB mediated expression of
cytokines.
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